OTCMKTS:NACNF

Meta Growth Competitors

C$0.10
-0.01 (-5.71 %)
(As of 11/18/2020)
Add
Compare
Today's Range
C$0.10
Now: C$0.10
C$0.12
50-Day Range
C$0.10
MA: C$0.10
C$0.10
52-Week Range
C$0.04
Now: C$0.10
C$0.35
Volume10,800 shs
Average Volume47,691 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Meta Growth (OTCMKTS:NACNF) Vs. TGIFF, FFNTF, ABSCF, ABAHF, ATTBF, and ACRDF

Should you be buying NACNF stock or one of its competitors? Companies in the sector of "medical" are considered alternatives and competitors to Meta Growth, including 1933 Industries (TGIFF), 4Front Ventures (FFNTF), AB Science (ABSCF), Abacus Health Products (ABAHF), Abattis Bioceuticals (ATTBF), and Acreage (ACRDF).

Meta Growth (OTCMKTS:NACNF) and 1933 Industries (OTCMKTS:TGIFF) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, risk, institutional ownership, earnings, valuation, dividends and analyst recommendations.

Profitability

This table compares Meta Growth and 1933 Industries' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Meta GrowthN/AN/AN/A
1933 IndustriesN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and target prices for Meta Growth and 1933 Industries, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Meta Growth00203.00
1933 Industries01002.00

Meta Growth currently has a consensus price target of C$0.30, indicating a potential upside of 203.03%. Given Meta Growth's stronger consensus rating and higher probable upside, equities research analysts plainly believe Meta Growth is more favorable than 1933 Industries.

Valuation and Earnings

This table compares Meta Growth and 1933 Industries' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Meta GrowthN/AN/AN/AN/AN/A
1933 IndustriesN/AN/AN/AN/AN/A

Summary

Meta Growth beats 1933 Industries on 3 of the 3 factors compared between the two stocks.

Meta Growth (OTCMKTS:NACNF) and 4Front Ventures (OTCMKTS:FFNTF) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, risk, institutional ownership, earnings, valuation, dividends and analyst recommendations.

Profitability

This table compares Meta Growth and 4Front Ventures' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Meta GrowthN/AN/AN/A
4Front VenturesN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and target prices for Meta Growth and 4Front Ventures, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Meta Growth00203.00
4Front Ventures0000N/A

Meta Growth currently has a consensus price target of C$0.30, indicating a potential upside of 203.03%. Given Meta Growth's higher probable upside, equities research analysts plainly believe Meta Growth is more favorable than 4Front Ventures.

Valuation and Earnings

This table compares Meta Growth and 4Front Ventures' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Meta GrowthN/AN/AN/AN/AN/A
4Front VenturesN/AN/AN/AN/AN/A

Summary

Meta Growth beats 4Front Ventures on 2 of the 2 factors compared between the two stocks.

Meta Growth (OTCMKTS:NACNF) and AB Science (OTCMKTS:ABSCF) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, risk, institutional ownership, earnings, valuation, dividends and analyst recommendations.

Profitability

This table compares Meta Growth and AB Science's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Meta GrowthN/AN/AN/A
AB ScienceN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and target prices for Meta Growth and AB Science, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Meta Growth00203.00
AB Science00103.00

Meta Growth currently has a consensus price target of C$0.30, indicating a potential upside of 203.03%. Given Meta Growth's higher probable upside, equities research analysts plainly believe Meta Growth is more favorable than AB Science.

Valuation and Earnings

This table compares Meta Growth and AB Science's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Meta GrowthN/AN/AN/AN/AN/A
AB ScienceN/AN/AN/AN/AN/A

Summary

Meta Growth beats AB Science on 2 of the 2 factors compared between the two stocks.

Meta Growth (OTCMKTS:NACNF) and Abacus Health Products (OTCMKTS:ABAHF) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, risk, institutional ownership, earnings, valuation, dividends and analyst recommendations.

Profitability

This table compares Meta Growth and Abacus Health Products' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Meta GrowthN/AN/AN/A
Abacus Health ProductsN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and target prices for Meta Growth and Abacus Health Products, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Meta Growth00203.00
Abacus Health Products0000N/A

Meta Growth currently has a consensus price target of C$0.30, indicating a potential upside of 203.03%. Given Meta Growth's higher probable upside, equities research analysts plainly believe Meta Growth is more favorable than Abacus Health Products.

Valuation and Earnings

This table compares Meta Growth and Abacus Health Products' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Meta GrowthN/AN/AN/AN/AN/A
Abacus Health ProductsN/AN/AN/AN/AN/A

Summary

Meta Growth beats Abacus Health Products on 2 of the 2 factors compared between the two stocks.

Meta Growth (OTCMKTS:NACNF) and Abattis Bioceuticals (OTCMKTS:ATTBF) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, risk, institutional ownership, earnings, valuation, dividends and analyst recommendations.

Profitability

This table compares Meta Growth and Abattis Bioceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Meta GrowthN/AN/AN/A
Abattis BioceuticalsN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and target prices for Meta Growth and Abattis Bioceuticals, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Meta Growth00203.00
Abattis Bioceuticals0000N/A

Meta Growth currently has a consensus price target of C$0.30, indicating a potential upside of 203.03%. Given Meta Growth's higher probable upside, equities research analysts plainly believe Meta Growth is more favorable than Abattis Bioceuticals.

Valuation and Earnings

This table compares Meta Growth and Abattis Bioceuticals' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Meta GrowthN/AN/AN/AN/AN/A
Abattis BioceuticalsN/AN/AN/AN/AN/A

Summary

Meta Growth beats Abattis Bioceuticals on 2 of the 2 factors compared between the two stocks.

Meta Growth (OTCMKTS:NACNF) and Acreage (OTCMKTS:ACRDF) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, risk, institutional ownership, earnings, valuation, dividends and analyst recommendations.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Meta Growth and Acreage, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Meta Growth00203.00
Acreage00103.00

Meta Growth currently has a consensus price target of C$0.30, indicating a potential upside of 203.03%. Acreage has a consensus price target of $6.00, indicating a potential upside of 131.53%. Given Meta Growth's higher probable upside, equities research analysts plainly believe Meta Growth is more favorable than Acreage.

Profitability

This table compares Meta Growth and Acreage's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Meta GrowthN/AN/AN/A
AcreageN/AN/AN/A

Valuation and Earnings

This table compares Meta Growth and Acreage's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Meta GrowthN/AN/AN/AN/AN/A
AcreageN/AN/AN/AN/AN/A

Summary

Meta Growth beats Acreage on 2 of the 2 factors compared between the two stocks.


Meta Growth Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
1933 Industries logo
TGIFF
1933 Industries
0.0$0.08-0.3%$0.00N/A0.00Gap Down
4Front Ventures logo
FFNTF
4Front Ventures
0.0$1.19-1.7%$0.00N/A0.00Gap Down
AB Science logo
ABSCF
AB Science
0.8$19.62-1.4%$0.00N/A0.00
ABAHF
Abacus Health Products
0.4$4.84-5.4%$0.00N/A0.00Gap Up
Abattis Bioceuticals logo
ATTBF
Abattis Bioceuticals
0.4$0.02-8.8%$0.00N/A0.00Gap Up
Acreage logo
ACRDF
Acreage
1.7$2.59-1.3%$0.00N/A0.00
Acreage logo
ACRGF
Acreage
1.2$2.77-0.9%$0.00N/A0.00
ACRHF
Acreage
0.6$5.50-2.3%$0.00N/A0.00Gap Down
Acusphere logo
ACUS
Acusphere
0.0$0.04-24.8%$0.00N/A0.00Gap Down
ADiTx Therapeutics logo
ADTX
ADiTx Therapeutics
1.0$2.60-3.5%$0.00N/A0.00Gap Up
ALGXY
Affinity Energy and Health
0.4$0.00-169,900.0%$0.00$2.05 million0.00Gap Up
Affymax logo
AFFY
Affymax
0.6$0.08-10.8%$0.00N/A0.00Gap Up
AGL
agilon health
0.0$30.00-3.3%$0.00N/A0.00High Trading Volume
Gap Up
AgraFlora Organics International logo
AGFAF
AgraFlora Organics International
0.8$0.03-9.2%$0.00N/A0.00Gap Up
AKYA
Akoya BioSciences
0.0$26.05-0.2%$0.00N/A0.00High Trading Volume
AKSY
Aksys
0.0$0.05-99.0%$0.00N/A0.00Gap Down
Aleafia Health logo
ALEAF
Aleafia Health
0.0$0.46-0.9%$0.00N/A0.00
Algernon Pharmaceuticals logo
AGNPF
Algernon Pharmaceuticals
0.0$0.13-1.8%$0.00N/A0.00
Almirall logo
LBTSF
Almirall
0.5$15.00-1.3%$0.00N/A0.00
Ambu A/S logo
AMBBY
Ambu A/S
0.4$54.80-6.2%$0.00N/A0.00Analyst Report
Decrease in Short Interest
Gap Down
American Green logo
ERBB
American Green
1.0$0.01-3.9%$0.00N/A0.00
AOBI
American Oriental Bioengineering
0.4$1.50-0.0%$0.00N/A0.00
Ansell logo
ANSLF
Ansell
0.6$29.00-0.0%$0.00N/A0.00
Ansell logo
ANSLY
Ansell
0.5$120.07-1.7%$0.00N/A0.00
APHQF
Aphria
0.6$11.57-3.1%$0.00N/A0.00Gap Down
Apotheca Biosciences logo
CBDC
Apotheca Biosciences
0.4$0.08-6.7%$0.00N/A0.00High Trading Volume
Gap Up
Applied Biosciences logo
APPB
Applied Biosciences
0.5$0.22-77.3%$0.00N/A0.00Increase in Short Interest
Gap Up
Arjo AB (publ) logo
ARRJF
Arjo AB (publ)
0.2$7.38-8.7%$0.00N/A0.00High Trading Volume
Gap Up
ARNI
Arno Therapeutics
0.5$0.01-23.1%$0.00N/A0.00Gap Up
ARYX
ARYx Therapeutics
0.0$0.01-0.0%$0.00N/A0.00Gap Down
Aspyra logo
APYI
Aspyra
0.0$0.13-15.4%$0.00N/A0.00Gap Up
AHROQ
AtheroNova
0.0$0.01-14.8%$0.00N/A0.00Gap Up
Avid Bioservices logo
CDMOP
Avid Bioservices
0.3$25.06-0.0%$0.00N/A0.00
AVTI
Avitar
0.5$0.00-16.7%$0.00N/A0.00Gap Up
AXIM Biotechnologies logo
AXIM
AXIM Biotechnologies
0.4$0.65-11.2%$0.00N/A0.00Gap Up
AYRSF
Ayr Strategies
1.4$21.26-1.0%$0.00N/A0.00High Trading Volume
Gap Down
Ayr Wellness logo
AYRWF
Ayr Wellness
1.3$27.23-0.5%$0.00N/A0.00
BATM Advanced Communications logo
BTAVF
BATM Advanced Communications
1.0$1.26-2.4%$0.00N/A0.00Gap Up
BXRXV
Baudax Bio
0.5$4.51-22.2%$0.00N/A0.00High Trading Volume
Benchmark logo
BHCCF
Benchmark
1.0$0.79-0.0%$0.00N/A0.00
BerGenBio ASA logo
BRRGF
BerGenBio ASA
0.7$3.52-10.2%$0.00N/A0.00Gap Up
Bespoke Extracts logo
BSPK
Bespoke Extracts
0.3$0.02-2.0%$0.00N/A0.00Gap Down
BOSQF
Better Plant Sciences
0.8$0.07-1.4%$0.00N/A0.00Gap Down
Binovi Technologies logo
BNVIF
Binovi Technologies
0.0$0.06-2.7%$0.00N/A0.00Gap Down
BioGaia AB (publ) logo
BIOGY
BioGaia AB (publ)
0.0$25.39-0.4%$0.00N/A0.00
Biome Grow logo
BIOIF
Biome Grow
0.0$0.07-13.9%$0.00N/A0.00Gap Up
BMEA
Biomea Fusion
0.0$18.60-7.5%$0.00N/A0.00High Trading Volume
BIOYF
BioSyent
0.4$6.13-0.4%$0.00N/A0.00Gap Down
BioTech Medics logo
BMCS
BioTech Medics
0.0$0.08-30.0%$0.00N/A0.00Increase in Short Interest
BOIRF
Boiron
0.0$41.40-6.0%$0.00N/A0.00Gap Up
This page was last updated on 4/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.